Mounjaro and Wegovy in Fifth Settlement: Where to start and how to follow up
If you are looking for Mounjaro in Fifth Settlement or Wegovy in New Cairo, you can begin with a specialist medical consultation at the La Rose Fifth Settlement branch, located in CMC Medical Mall, 4th floor, North 90th Street, directly behind the Air Force Specialized Hospital. The clinic operates on Wednesdays from 3:30 to 8 pm with Dr. Shimaa Fouad, a physician, specialist in clinical and therapeutic nutrition, and member of the European Society for Clinical Nutrition and Metabolism (ESPEN). The consultation includes a comprehensive medical evaluation, an InBody body composition scan to monitor fat and protect muscle mass in objective numbers, body-contouring measurements, and a thorough review of laboratory tests, medical history, and medications to select the right personalized pathway [1, 2, 4].
On this page, you will learn who is eligible for weight-loss injections, who must avoid them completely, and the difference between starting a fresh course and switching between Mounjaro and Wegovy when weight plateaus. We also cover approved Wegovy indications for cardiovascular risk reduction, how to protect lean muscle mass against rapid loss, and why genuine injections are prescribed for dispensing at licensed pharmacies rather than sold inside clinics. Finally, we explain how to select an accredited follow-up clinic and reach our Fifth Settlement location smoothly from nearby neighbourhoods [1, 3, 5].
Who is eligible for weight-loss injections, and who should avoid them?
Weight-management injections such as Mounjaro and Wegovy are neither cosmetic treatments nor quick fixes to shed a few kilograms before an event. Regulatory standards define adult eligibility at a body mass index (BMI) of 30 or higher, or 27 and higher alongside a weight-related condition such as high blood pressure, type 2 diabetes, or dyslipidemia. For Wegovy specifically, approval extends to adolescents aged 12 and older whose BMI reaches the 95th percentile or higher for age and sex on standardized pediatric growth charts [1, 3, 4].
Conversely, there are absolute contraindications where these medications must not be used under any circumstances. The most critical is a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN2), which is an explicit boxed warning across official product labels. These injections are also strictly contraindicated in cases of known serious hypersensitivity to the active substance or excipients, as well as during pregnancy, conception planning, or breastfeeding, because fetal safety is not established [1, 2, 3].
A specialist physician evaluates every detail of your medical history, examining the thyroid gland and checking kidney function, liver status, and pancreatic health before prescribing any injection. You can explore comprehensive details about eligibility for weight-loss injections to understand how clinical criteria are measured and what initial laboratory screening is essential [1, 4].
Starting fresh and switching between injections: escalation and safety rules
If you are starting weight-management injections for the first time, the foundational rule is to begin at the lowest introductory dose (0.25 mg weekly for semaglutide or 2.5 mg weekly for tirzepatide) and remain on it for at least four weeks before considering any increase. The primary purpose of this initiation phase is not immediate massive weight loss, but allowing the gastrointestinal tract and pancreas to adapt smoothly, thereby minimizing nausea, bloating, and reflux. Rushing dose escalation prematurely triggers severe gastrointestinal intolerance and frequently leads individuals to discontinue beneficial therapy altogether [1, 2, 12].
If you are transitioning from another medication such as Wegovy, Ozempic, or Saxenda to Mounjaro, the protocol requires careful medical management. Mounjaro is a dual-target agonist stimulating both GIP and GLP-1 receptors, whereas Wegovy acts selectively on GLP-1 receptors. Consequently, even if someone tolerated maximum semaglutide doses, they cannot simply leap to maximum tirzepatide strengths; a physician establishes an appropriate washout or transition step and a structured dose titration to prevent acute intolerance or severe digestive distress. You can explore the differences between Ozempic, Wegovy and Mounjaro to see how their mechanisms and metabolic impacts vary [1, 2, 7].
It is equally vital to adhere to the established dose escalation for Mounjaro and Wegovy set out in clinical guidelines, without doubling doses or counting pen clicks independently. The US FDA has issued explicit alerts regarding manual pen-splitting and unverified dose adjustments, as measurement errors have caused significant clinical complications requiring hospitalization [5, 12, 13].
Wegovy indications: obesity management and cardiovascular protection
Wegovy (semaglutide, up to a maximum maintenance dose of 2.4 mg once weekly) is far more than an appetite suppressant; it is an established medication with explicit regulatory approvals for chronic obesity management and its complications. The seminal STEP clinical trial programme demonstrated substantial, sustained body weight reduction when combined with lifestyle interventions, compared with placebo. These benefits were accompanied by notable reductions in waist circumference, blood pressure improvements, and favorable shifts in glycemic and lipid parameters [1, 8].
The most significant clinical expansion for Wegovy stems from the landmark SELECT cardiovascular outcomes trial published in the NEJM (Lincoff et al.), which tracked thousands of overweight or obese adults with pre-existing cardiovascular disease and no diabetes. The study documented a 20% reduction in major adverse cardiovascular events (MACE), encompassing cardiovascular death, non-fatal myocardial infarction, and non-fatal stroke. Based on this robust evidence, the US FDA updated Wegovy’s official prescribing information to include cardiovascular risk reduction in eligible adults, cementing its role as a vital cardioprotective therapy [1, 6].
Meanwhile, Mounjaro (tirzepatide) in the SURMOUNT clinical trials demonstrated profound weight reductions and marked improvements in insulin sensitivity driven by dual GIP and GLP-1 receptor activation. However, selecting between Wegovy and Mounjaro must always be guided by a physician assessing cardiovascular status, glycemic history, and individual tolerability, rather than online trends or peer anecdotes [2, 3, 7].
Protecting muscle mass with InBody testing: why the scale alone is not enough
One of the most serious pitfalls in medically supervised weight loss is relying exclusively on a conventional bathroom scale. A standard scale reports total body mass without distinguishing whether you are losing adipose tissue, essential skeletal muscle, or intracellular fluid. Clinical investigations and body composition reviews (including Look et al. from the SURMOUNT trial programme and Holmes & Racette) demonstrate that rapid, unguided weight loss carries a risk of substantial lean muscle loss, which diminishes basal metabolic rate, impairs physical strength, and accelerates weight regain upon treatment cessation [7, 9, 10].
For this reason, clinical assessment in nutritional practice relies on multi-frequency bioelectrical impedance analysis (BIA) using specialized InBody technology. Published clinical research (Looney et al.) confirms the high reliability and reproducibility of multi-frequency BIA in tracking segmental skeletal muscle mass, body fat percentage, and visceral adipose tissue across the trunk and limbs over time. This objective data enables the clinician to confirm whether weight loss consists predominantly of fat or whether protein intake and dietary strategy require immediate optimization [9, 10, 11].
At La Rose, Dr. Shimaa Fouad constructs an individualized nutrition protocol ensuring adequate high-quality dietary protein intake, strategic meal spacing despite reduced appetite, and guidance on suitable resistance exercises. Preserving lean muscle is the ultimate safeguard to sustain high metabolic health and achieve lasting vitality without severe lethargy or excessive muscle wasting [10, 11].
What happens during a La Rose Fifth Settlement consultation?
A consultation at the Fifth Settlement branch is structured to provide comprehensive clinical insight rather than a generic diet sheet. The clinic welcomes patients every Wednesday from 3:30 to 8 pm at CMC Medical Mall, 4th floor, led by Dr. Shimaa Fouad with over 18 years of clinical nutrition experience managing obesity, insulin resistance, and endocrine metabolic disorders. Your initial appointment allocates thorough time to explore your health history, lab tests, and daily lifestyle [4, 10].
The consultation encompasses five defined clinical steps: 1. Full clinical InBody assessment: rigorous measurement of body fat percentage, skeletal muscle mass, visceral fat score, and total body water. 2. Body-contouring measurement: recording target circumference metrics in centimetres to evaluate anatomical progress objectively rather than subjectively. 3. Medical and laboratory review: detailed evaluation of kidney function, liver enzymes, HbA1c, complete blood count, thyroid panels, and current medications. 4. Formulating the personalized pathway: deciding whether therapeutic nutrition alone, medically supervised injections, non-surgical body-contouring sessions, or a combined approach best serves your goals. 5. Official prescription: when weight-loss injections are clinically indicated, an official prescription is provided for dispensing at licensed community pharmacies; [4, 10, 12].
Weekly Wednesday follow-ups establish a consistent rhythm to assess treatment tolerability, manage common gastrointestinal symptoms like mild nausea or reflux promptly, and repeat InBody testing to confirm muscle preservation alongside fat reduction. Continuous physician oversight represents the essential difference between safe, lasting success and random unsupervised self-administration [12, 13].
How to choose a clinic for weight-loss injections in New Cairo
With widespread discussions about weight-loss injections across social media, it is vital to distinguish between rigorous clinical management and commercial marketing. A trustworthy medical service adheres to defined benchmarks: an examination by a qualified medical physician who reviews labs and medical history, routine body composition assessments via validated BIA to monitor muscle alongside fat, absolute transparency in prescribing through official prescriptions dispensed at licensed pharmacies rather than vials of unknown origin, and structured follow-up without inflated promises of unrealistic kilograms lost [4, 5, 14].
When considering medical options in Fifth Settlement and New Cairo, practical pathways in priority order include: 1. La Rose, Fifth Settlement branch: CMC Medical Mall, 4th floor, North 90th Street, operating Wednesdays 3:30 to 8 pm with Dr. Shimaa Fouad. Patients value the physician's 18+ years of clinical nutrition experience and ESPEN membership, comprehensive InBody scanning and body-contouring measurement in the same consultation, and weekly follow-up tailored to New Cairo residents. 2. Hospital-based obesity and endocrinology clinics: an appropriate choice for patients presenting with complex multi-organ comorbidities requiring integrated hospital departments or multidisciplinary inpatient monitoring. 3. University hospital outpatient specialty clinics: offering comprehensive diagnostic evaluations for complex or atypical metabolic presentations. 4. A specialized bariatric surgical consultation: for individuals with a BMI of 40 or higher, or 35 and higher with severe comorbidities who have not achieved necessary clinical outcomes through non-surgical therapies, referral for surgical evaluation represents an established evidence-based route [4, 14].
The right clinic prioritizes your long-term health, transparently outlines potential adverse effects, and equips you with sustainable nutritional and movement habits that endure long after medical therapy concludes [5, 14].
Fifth Settlement address, hours and booking
The address of La Rose Fifth Settlement is: CMC Medical Mall, 4th floor, North 90th Street, directly behind the Air Force Specialized Hospital, Fifth Settlement, New Cairo. The nutrition and weight-management clinic with Dr. Shimaa Fouad runs on Wednesdays from 3:30 to 8 pm. Schedules can vary, so confirm the day and time when booking by calling or messaging WhatsApp on 010 4066 1893.
The clinic location is easily accessible from key New Cairo areas verified with exact driving distances on the map: Cairo Festival City is about 5.2 km and approximately 10 minutes by car via South 90th Street; El Yasmeen is about 5 km and roughly 10 minutes via North 90th Street or Moustafa Kamel Axis; Al Narges is about 6.5 km and 12 minutes via South 90th Street; El Banafseg is about 6.9 km and 10 minutes via North 90th Street; First Settlement is about 7.4 km and 12 minutes via Moustafa Kamel Axis; and Point 90 Mall and AUC Avenue are about 9 km and 12 minutes by car. Travel times are typical and may vary with traffic.
If you experience severe, persistent upper abdominal pain radiating to the back accompanied by repeated vomiting, symptoms of pronounced dehydration, or difficulty breathing with facial swelling, do not wait for your appointment; seek emergency care immediately, as these warning signs may indicate acute pancreatitis or severe allergic reactions requiring urgent intervention [14, 15]. You can review our dedicated resource on red flags and serious side effects of weight-loss injections for detailed safety guidance. For non-emergency care, Book at the Fifth Settlement branch to embark on an evidence-based, medically guided journey [14].
